| PI | SF | Funding Agency | Title | Project | Topic | Details |
|---|---|---|---|---|---|---|
| John V. Frangioni | Kemp Fund | Paul D. and Lovie S. Kemp Career Development Fund for Prostate Cancer | Tumor and Disease Targeted Agents | Contrast Agent Chemistry | Details | |
| John V. Frangioni | CIMIT | Functional Inoperative Imaging | FLARE™ and NIR Imaging Systems | Imaging System Engineering | Details | |
| John V. Frangioni | CIMIT | Improved Deep-Tissue Sensitivity for Intraoperative NIR Fluorescence Imaging | FLARE™ and NIR Imaging Systems | Imaging System Engineering | Details | |
| John V. Frangioni | HHMI | Postdoctoral Research Fellowship for Physicians | FLARE™ and NIR Contrast Agents | Targeting Ligand Development | Details | |
| John V. Frangioni | AACR | Sub-Nuclear Targeting and Functioning of CAMP-Regulated Histone Acetyltransferase | Cell Biology and Subcellular Localization | Tumor Biology and Cytotherapy | Details | |
| John V. Frangioni | Stewart Trust | A Molecular Diversity Approach to Cancer Detection | Tumor and Disease Targeted Agents | Targeting Ligand Development | Details | |
| John V. Frangioni | NCI | Low-Molecular Weight Ligands for Prostate Cancer | Tumor and Disease Targeted Agents | Targeting Ligand Development | Details | |
| John V. Frangioni | DDCF | Low-Molecular Weight Ligands for Bladder Cancer | Phage Display and Protein Expression | Targeting Ligand Development | Details | |
| John V. Frangioni | NCI | Molecular Imaging of Advanced Bladder Cancer | Tumor and Disease Targeted Agents | Targeting Ligand Development | Details | |
| John V. Frangioni | DOE | Near-Infrared Fluorescent Ligands for Bladder Cancer | FLARE™ and NIR Imaging Systems | Imaging System Engineering | Details | |
| John V. Frangioni | NIBIB | Near Infrared Quantum Dots for In Vivo Imaging | Nanoparticles and Polymers | Contrast Agent Chemistry | Details | |
| John V. Frangioni | NCI | Improved Optical Sub-System for In Vivo Cancer Imaging | FLARE™ and NIR Imaging Systems | Imaging System Engineering | Details | |
| John V. Frangioni | NHLBI | Optical & MRI of Stem Cells in Diseased Hearts | MRI Agents and Technology, FLARE™ and NIR Contrast Agents | Physiology and ADME-Tox | Details | |
| John V. Frangioni | GE | GE Industrial Support/ NIR Fluorescence | FLARE™ and NIR Imaging Systems | Imaging System Engineering | Details | |
| John V. Frangioni | CIMIT | Artificial Proton/New Concept | MRI Agents and Technology | Contrast Agent Chemistry | Details | |
| John V. Frangioni | CIMIT | Artificial Proton/Application Development | MRI Agents and Technology | Contrast Agent Chemistry | Details | |
| John V. Frangioni | LSAIF | NCRR | FLEX™ microPET/SPECT/CT to Support Cancer Research at Harvard Medical School | Animal Model Systems, Tumor and Disease Targeted Agents, BioD/PK/Clearance, Radiotracer Development | Small Animal Imaging | Details |
| John V. Frangioni | MTTC | A Handheld NIR Fluorescence Imaging System for Surgery and Beyond | FLARE™ and NIR Imaging Systems | Imaging System Engineering | Details | |
| John V. Frangioni | GE | Optimization of Intraoperative Imaging Applications | FLARE™ and NIR Contrast Agents | Contrast Agent Chemistry | Details | |
| John V. Frangioni | GE | GE Nerve Contrast Agent Development | Normal Tissue/Organ Targeted Agents, FLARE™ and NIR Contrast Agents | Targeting Ligand Development, Contrast Agent Chemistry | Details |